Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Targeting SLC1A5 and SLC3A2/SLC7A5 as a Potential Strategy to Strengthen Anti-Tumor Immunity in the Tumor Microenvironment
Marianna Nachef, Alaa Kassim Ali, Saeedah Musaed Almutairi, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 110

Showing 1-25 of 110 citing articles:

Targeting glutamine metabolism as a therapeutic strategy for cancer
Jonghwa Jin, Jun‐Kyu Byun, Yeon‐Kyung Choi, et al.
Experimental & Molecular Medicine (2023) Vol. 55, Iss. 4, pp. 706-715
Open Access | Times Cited: 216
Reuterin in the healthy gut microbiome suppresses colorectal cancer growth through altering redox balance
Hannah N. Bell, Ryan Rebernick, Joshua Goyert, et al.
Cancer Cell (2021) Vol. 40, Iss. 2, pp. 185-200.e6
Open Access | Times Cited: 186
Glutamine metabolism in breast cancer and possible therapeutic targets
Shiqi Li, Hui Zeng, Junli Fan, et al.
Biochemical Pharmacology (2023) Vol. 210, pp. 115464-115464
Closed Access | Times Cited: 54
Breakthrough of solid tumor treatment: CAR-NK immunotherapy
Wenkang Wang, Yang Liu, Zhen He, et al.
Cell Death Discovery (2024) Vol. 10, Iss. 1
Open Access | Times Cited: 48
A glutamine tug-of-war between cancer and immune cells: recent advances in unraveling the ongoing battle
Bolin Wang, Jinli Pei, Shengnan Xu, et al.
Journal of Experimental & Clinical Cancer Research (2024) Vol. 43, Iss. 1
Open Access | Times Cited: 24
Acidosis activates breast cancer ferroptosis through ZFAND5/SLC3A2 signaling axis and elicits M1 macrophage polarization
Hanchu Xiong, Yanan Zhai, Yimei Meng, et al.
Cancer Letters (2024) Vol. 587, pp. 216732-216732
Closed Access | Times Cited: 21
Glutamine antagonist DRP-104 suppresses tumor growth and enhances response to checkpoint blockade in KEAP1 mutant lung cancer
Ray Pillai, Sarah E. LeBoeuf, Yuan Hao, et al.
Science Advances (2024) Vol. 10, Iss. 13
Open Access | Times Cited: 20
Tumor metabolic regulators: key drivers of metabolic reprogramming and the promising targets in cancer therapy
Kun Huang, Ying Han, Yihong Chen, et al.
Molecular Cancer (2025) Vol. 24, Iss. 1
Open Access | Times Cited: 2
Targeting estrogen-regulated system xc− promotes ferroptosis and endocrine sensitivity of ER+ breast cancer
Jiawei Cao, Tong Zhou, Tom Wu, et al.
Cell Death and Disease (2025) Vol. 16, Iss. 1
Open Access | Times Cited: 2
Tryptophan and its metabolites in normal physiology and cancer etiology
Lizbeth Perez‐Castro, R. Bayes Garcia, Niranjan Venkateswaran, et al.
FEBS Journal (2021) Vol. 290, Iss. 1, pp. 7-27
Open Access | Times Cited: 66
Mitochondria dysfunction in CD8+ T cells as an important contributing factor for cancer development and a potential target for cancer treatment: a review
Lu Zhang, Wen Zhang, Ziye Li, et al.
Journal of Experimental & Clinical Cancer Research (2022) Vol. 41, Iss. 1
Open Access | Times Cited: 47
SLC1A5 enhances malignant phenotypes through modulating ferroptosis status and immune microenvironment in glioma
Liying Han, Jinpeng Zhou, Leiyang Li, et al.
Cell Death and Disease (2022) Vol. 13, Iss. 12
Open Access | Times Cited: 46
HIF: a master regulator of nutrient availability and metabolic cross‐talk in the tumor microenvironment
Rindert Missiaen, Nicholas P. Lesner, M. Celeste Simon
The EMBO Journal (2023) Vol. 42, Iss. 6
Open Access | Times Cited: 35
Amino acid metabolism reprogramming: shedding new light on T cell anti-tumor immunity
Yue Zheng, Yiran Yao, Tongxin Ge, et al.
Journal of Experimental & Clinical Cancer Research (2023) Vol. 42, Iss. 1
Open Access | Times Cited: 23
Advances in metabolic reprogramming of NK cells in the tumor microenvironment on the impact of NK therapy
Linxuan Miao, Chenglin Lu, Bin Zhang, et al.
Journal of Translational Medicine (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 14
Molecular mechanisms and therapeutic significance of Tryptophan Metabolism and signaling in cancer
Jing Yan, Di Chen, Zi Ye, et al.
Molecular Cancer (2024) Vol. 23, Iss. 1
Closed Access | Times Cited: 11
The Cancer Antioxidant Regulation System in Therapeutic Resistance
Xuanhao Gu, Chunyang Mu, Rujia Zheng, et al.
Antioxidants (2024) Vol. 13, Iss. 7, pp. 778-778
Open Access | Times Cited: 10
CAR memory–like NK cells targeting the membrane proximal domain of mesothelin demonstrate promising activity in ovarian cancer
Mubin Tarannum, Khanhlinh Dinh, Juliana Vergara, et al.
Science Advances (2024) Vol. 10, Iss. 28
Open Access | Times Cited: 9
The Impact of Metabolic Rewiring in Glioblastoma: The Immune Landscape and Therapeutic Strategies
Yuganthini Vijayanathan, Ivy A. W. Ho
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 2, pp. 669-669
Open Access | Times Cited: 1
Bioinformatics analysis of genes associated with disulfidptosis in spinal cord injury
Shuang Wang, Xinhua Liu, Jun Tian, et al.
PLoS ONE (2025) Vol. 20, Iss. 2, pp. e0318016-e0318016
Open Access | Times Cited: 1
Solute carriers: The gatekeepers of metabolism
Artem Khan, Yuyang Liu, Mark Gad, et al.
Cell (2025) Vol. 188, Iss. 4, pp. 869-884
Closed Access | Times Cited: 1
Bridging epigenomics and tumor immunometabolism: molecular mechanisms and therapeutic implications
Xiaowen Xie, Weici Liu, Zhiyuan Yuan, et al.
Molecular Cancer (2025) Vol. 24, Iss. 1
Open Access | Times Cited: 1
Colorectal cancer: Metabolic interactions reshape the tumor microenvironment
Jiawei Chen, Haodong Zhu, Yuhang Yin, et al.
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2022) Vol. 1877, Iss. 5, pp. 188797-188797
Closed Access | Times Cited: 35
The role of branched chain amino acids metabolic disorders in tumorigenesis and progression
Jingtong Wang, Wei Wang, Feng Zhu, et al.
Biomedicine & Pharmacotherapy (2022) Vol. 153, pp. 113390-113390
Open Access | Times Cited: 29
CD98 heavy chain as a prognostic biomarker and target for cancer treatment
Xia Pu, Anna Dubrovska
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 18
Page 1 - Next Page

Scroll to top